Genmab
GMAB
#780
Rank
HK$248.50 B
Marketcap
HK$403.02
Share price
-0.72%
Change (1 day)
70.47%
Change (1 year)

EPS for Genmab (GMAB)

EPS in 2026 (TTM): HK$13.98

According to Genmab's latest financial reports the company's current EPS (TTM) is HK$14.02. In 2025 the company made an earnings per share (EPS) of HK$12.16 a decrease over its 2024 EPS that were of HK$13.38.

EPS history for Genmab from 2002 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$13.9814.94%
2025HK$12.16-9.09%
2024HK$13.3876.32%
2023HK$7.59-20.44%
2022HK$9.5473.57%
2021HK$5.49-41.96%
2020HK$9.47133.96%
2019HK$4.0540.1%
2018HK$2.8925.93%
2017HK$2.294.18%
2016HK$2.2046.79%
2015HK$1.50118.84%
2014HK$0.69114.51%
2013HK$0.32-121.72%
2012-HK$1.47-19.1%
2011-HK$1.8281.46%
2010-HK$1.00-70.53%
2009-HK$3.407.24%
2008-HK$3.17137.03%
2007-HK$1.34-14.43%
2006-HK$1.56-0.22%
2005-HK$1.57-30.15%
2004-HK$2.2417.97%
2003-HK$1.90-20.22%
2002-HK$2.38